<DOC>
	<DOCNO>NCT00849563</DOCNO>
	<brief_summary>The primary objective study assess clinical utility genetic test Type 2 diabetes risk combination standardize risk assessment compare standardize risk assessment alone , measure whether change perceive risk follow genetic test Type 2 diabetes risk correlate behavior change increase concern risk Type 2 diabetes .</brief_summary>
	<brief_title>Effect Type 2 Diabetes Genetic Risk Information Health Behaviors Outcomes</brief_title>
	<detailed_description>One thousand outpatient enrol two year two university-affiliated primary care clinic . Patients assign one three study arm : want genetic testing diabetes risk randomly assign either receive test addition SRA ( SRA+G ) receive SRA ( SRA-only ) . Those wish genetic test receive SRA . All patient survey baseline , immediately go SRA ( risk-counseling visit ; 2-4 week initial visit ) , 3 month post risk counsel visit 12 month post risk counsel visit . BMI , waist circumference , fast plasma glucose insulin measure baseline 12 month . Surveys allow u track patient ' emotional response diabetes risk information change perception personal risk Type 2 diabetes time , see correlate subsequent diet exercise behavior . We use linear model ass effect genetic testing among three study group , use HOmeostasis Model Assessment Insulin Resistance ( HOMA-IR ) weight loss primary outcome . We use generalized linear ordinal regression model fit ordinal survey outcomes risk perception continuous HOMA-IR weight outcome variable .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Are male female outpatient No selfreported history diabetes No selfreported history prior genetic test diabetes Not pregnant ( self report ) Are â‰¥18 &lt; 81 year age Scheduled receive serum glucose test participate clinic Fasting time blood draw ( food drink except water previous 8 hour : self report ) Able willing give legally effective consent Able willing participate patient questionnaire Ambulatory Previously currently take medication lower glucose ( i.e. , exenatide , pramlintide , metformin , rosiglitazone , pioglitazone , future diabetes drug ) base selfreport and/or prescreening Selfreport current prior diabetes diagnosis Selfreported prior history genetic testing diabetes Baseline serum glucose test result &gt; 125</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>predictive genomics</keyword>
	<keyword>personalize medicine</keyword>
	<keyword>personal genomics</keyword>
	<keyword>genetic knowledge</keyword>
	<keyword>genetic attitude</keyword>
	<keyword>prevention</keyword>
	<keyword>health outcome</keyword>
	<keyword>behavioral</keyword>
</DOC>